PMID- 29331618 OWN - NLM STAT- MEDLINE DCOM- 20180816 LR - 20191210 IS - 1578-1267 (Electronic) IS - 0301-0546 (Linking) VI - 46 IP - 2 DP - 2018 Mar-Apr TI - Efficacy and safety of sublingual immunotherapy with Dermatophagoides farinae drops in pre-school and school-age children with allergic rhinitis. PG - 107-111 LID - S0301-0546(17)30182-9 [pii] LID - 10.1016/j.aller.2017.09.022 [doi] AB - BACKGROUND: The safety and efficacy of sublingual immunotherapy (SLIT) have been confirmed by many studies. However, in China, the research on efficacy and safety in young and older children with allergic rhinitis (AR) is still rare. OBJECTIVE: The aim of this retrospective study is to evaluate the efficacy and safety of SLIT with Dermatophagoides farinae drops in pre-school and school-age children with AR. METHODS: A total of 282 subjects aged 2-13 years with AR received a two-year course of sublingual immunotherapy along with pharmacotherapy. According to the age, patients were defined as the pre-school group (2-6 years old, n=116) and school-age group (7-13 years old, n=166). Total nasal rhinitis symptom scores (TNSS), visual analogue score (VAS) and total medication scores (TMS) were evaluated at four time points: baseline, after SLIT for half a year, one year and two years. The adverse events (AEs) were evaluated at each visit. RESULTS: After two-year SLIT, the four rhinitis symptom scores, TNSS, VAS and TMS scores were significantly lower than baseline (all P<0.05). The comparison of efficacy between one and two-year duration showed no significant difference in global clinical outcomes (all P>0.05). In addition, there were no significant differences between the pre-school and school-age group in TNSS (all P>0.05), VAS (all P>0.05) and TMS scores (P>0.05) after SLIT for half a year, one year and two years. No severe systemic AEs were reported. CONCLUSION: SLIT with D. farinae drops is clinically effective and safe in pre-school and school-age patients with house dust mites (HDMs)-induced AR. CI - Copyright (c) 2018 SEICAP. Published by Elsevier Espana, S.L.U. All rights reserved. FAU - Tang, L-X AU - Tang LX AD - Department of Otolaryngology-Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China. FAU - Yang, X-J AU - Yang XJ AD - Department of Otolaryngology-Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China. FAU - Wang, P-P AU - Wang PP AD - Department of Otolaryngology-Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China. FAU - Ge, W-T AU - Ge WT AD - Department of Otolaryngology-Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China. FAU - Zhang, J AU - Zhang J AD - Department of Otolaryngology-Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China. FAU - Guo, Y-L AU - Guo YL AD - Beijing Key Laboratory for Pediatric Diseases of Otolaryngology-Head and Neck Surgery, Beijing Pediatric Research Institute, Capital Medical University, Beijing 100020, China. FAU - Lu, J AU - Lu J AD - Beijing Key Laboratory for Pediatric Diseases of Otolaryngology-Head and Neck Surgery, Beijing Pediatric Research Institute, Capital Medical University, Beijing 100020, China. FAU - Tai, J AU - Tai J AD - Department of Otolaryngology-Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China. FAU - Zhang, Y-M AU - Zhang YM AD - Department of Otolaryngology-Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China. FAU - Ni, X AU - Ni X AD - Department of Otolaryngology-Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China; Beijing Key Laboratory for Pediatric Diseases of Otolaryngology-Head and Neck Surgery, Beijing Pediatric Research Institute, Capital Medical University, Beijing 100020, China. Electronic address: nixin@bch.com.cn. LA - eng PT - Evaluation Study PT - Journal Article DEP - 20180111 PL - Singapore TA - Allergol Immunopathol (Madr) JT - Allergologia et immunopathologia JID - 0370073 RN - 0 (Antigens, Dermatophagoides) SB - IM MH - Adolescent MH - Animals MH - Antigens, Dermatophagoides/immunology/*therapeutic use MH - Child MH - Child, Preschool MH - China MH - Dermatophagoides farinae/immunology MH - Female MH - Follow-Up Studies MH - Humans MH - Male MH - Population MH - Retrospective Studies MH - Rhinitis, Allergic/immunology/*therapy MH - Sublingual Immunotherapy/*methods OTO - NOTNLM OT - Allergic rhinitis OT - D. farinae OT - Efficacy OT - Sublingual immunotherapy EDAT- 2018/01/15 06:00 MHDA- 2018/08/17 06:00 CRDT- 2018/01/15 06:00 PHST- 2017/05/19 00:00 [received] PHST- 2017/07/31 00:00 [revised] PHST- 2017/09/13 00:00 [accepted] PHST- 2018/01/15 06:00 [pubmed] PHST- 2018/08/17 06:00 [medline] PHST- 2018/01/15 06:00 [entrez] AID - S0301-0546(17)30182-9 [pii] AID - 10.1016/j.aller.2017.09.022 [doi] PST - ppublish SO - Allergol Immunopathol (Madr). 2018 Mar-Apr;46(2):107-111. doi: 10.1016/j.aller.2017.09.022. Epub 2018 Jan 11.